세계의 파종성 혈관 내 응고(DIC) 시장 보고서(2025년)

Disseminated Intravascular Coagulation (DIC) Global Market Report 2025

US $ 4,490 ￦ 6,342,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,167,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,992,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

파종성 혈관 내 응고(DIC) 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 5.0%로 성장할 전망이며, 5억 9,000만 달러로 성장이 예측됩니다. 예측 기간 동안 성장은 표적 치료 채택 증가, 질환 조기 발견에 대한 관심 증가, 헬스케어 인프라에 대한 투자 증가, 응고 이상증 치료에 관한 임상 연구 확대, 희귀 혈액 질환에 대한 인식 증가 등에 기인할 것으로 보입니다. 주요 동향으로는 진단 분석 발전, 신규 항응고 요법 채택, 맞춤형 의료 접근법 대두, 진단에서의 AI 통합, 환자 모니터링 기술 향상, 표적 치료의 개발 등을 들 수 있습니다.

암의 이환율 상승이 파종성 혈관 내 응고(DIC) 시장의 성장을 견인할 것으로 예측됩니다. 암은 정상 조직에 침입하여 손상을 입히는 이상세포의 무질서한 증식 및 확산을 특징으로 하는 질환입니다. 암 환자의 증가는 고령화, 라이프 스타일 변화, 환경 폭로, 감염증, 유전적 소인 등의 요인에 기인하고 있습니다. 암은 종양이 생성하는 응고 촉진 물질에 의해 응고 캐스케이드를 과도하게 활성화시켜 광범위한 혈액 응고나 출혈을 초래함으로써 파종성 혈관 내 응고(DIC)를 일으킬 수 있습니다. 예를 들어 2024년 5월 미국 정부기관인 국립암연구소는 2022년 전 세계적으로 약 2,000만 명의 신규 암 환자와 970만 명의 암 관련 죽음이 기록됐다고 보고했습니다. 예측에 따르면, 이 숫자는 2040년까지 연간 2,990만 명의 신규 이환자와 1,530만 명의 사망자로 증가할 수 있습니다. 그 결과, 암 유병률 증가가 파종성 혈관 내 응고(DIC) 시장의 성장을 촉진하고 있습니다.

파종성 혈관 내 응고(DIC) 시장의 주요 기업은 차세대 혈액 응고 검사 등의 응고 진단 기술을 진보시켜 진단 정밀도, 속도, 편리성을 향상시키고 있습니다. 이러한 기술 혁신은 시의적절한 개입을 가능하게 하고, 환자의 전귀를 향상시킵니다. 차세대 혈액 응고 검사는 기존의 방법보다 더 정확하고 효율적이며 포괄적으로 혈액 응고를 평가하도록 설계된 고도의 진단 도구입니다. 예를 들어 2022년 6월 영국 헬스케어 기업인 루미라덱스 리미티드는 NT-프로BNP 검사와 갱신 D-다이머 검사에 대한 CE 마크 승인을 획득해 심혈관 검사 포트폴리오를 확충했습니다. 이러한 기능 강화로 루미라덱스 플랫폼은 심부전 진단과 정맥혈전색전증 제외를 포인트 오브 케어로 진행하는 임상의를 지원하는 능력을 강화했습니다. 이러한 진보는 파종성 혈관 내 응고(DIC)을 포함한 심혈관 및 혈전성 질환의 조기 발견과 관리를 개선하는 것을 목적으로 하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

• 세계의 파종성 혈관 내 응고(DIC) PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
• 최종 이용 산업의 분석
• 세계의 파종성 혈관 내 응고(DIC) 시장 : 성장률 분석
• 세계의 파종성 혈관 내 응고(DIC) 시장 실적 : 규모 및 성장(2019-2024년)
• 세계의 파종성 혈관 내 응고(DIC) 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
• 세계의 파종성 혈관 내 응고(DIC) 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 파종성 혈관 내 응고(DIC) 시장 : 치료별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 약
• 수혈
• 수술
• 기타 치료법
• 세계의 파종성 혈관 내 응고(DIC) 시장 : 진단별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 혈액 도말 표본 검사를 포함한 전혈구 산정
• 부분 트롬보플라스틴 시간(PTT)
• 피브리노겐 혈액 검사
• D 다이머
• 기타 진단
• 세계의 파종성 혈관 내 응고(DIC) 시장 : 투여 경로별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 오랄
• 비경구
• 기타 투여 경로
• 세계의 파종성 혈관 내 응고(DIC) 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 소매 약국
• 온라인 약국
• 세계의 파종성 혈관 내 응고(DIC) 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 전문 클리닉
• 홈케어
• 기타 최종 사용자
• 세계의 파종성 혈관 내 응고(DIC) 시장 : 의약품 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 항응고제
• 항혈소판약
• 선용약
• 응혈 촉진제
• 항트롬빈 요법
• 세계의 파종성 혈관 내 응고(DIC) 시장 : 수혈 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 혈소판 수혈
• 신선동결혈장(FFP)
• 클리오 프리시피테이트 수혈
• 적혈구 수혈
• 세계의 파종성 혈관 내 응고(DIC) 시장 : 수술 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 혈전의 외과적 제거
• 장기 수술
• 세계의 파종성 혈관 내 응고(DIC) 시장 : 기타 치료법별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 혈장 교환
• 지지요법
• 스테로이드 요법

제7장 지역별 및 국가별 분석

• 세계의 파종성 혈관 내 응고(DIC) 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 파종성 혈관 내 응고(DIC) 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

• 파종성 혈관 내 응고(DIC) 시장 : 경쟁 구도
• 파종성 혈관 내 응고(DIC) 시장 : 기업 프로파일
  • Nihon Kohden Corporation 개요, 제품 및 서비스, 전략 및 재무 분석
  • Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Johnson & Johnson 개요, 제품 및 서비스, 전략 및 재무 분석
  • F. Hoffmann-La Roche Ltd. 개요, 제품 및 서비스, 전략 및 재무 분석
  • AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Merck & Co.Inc.
• Bayer AG
• Sanofi SA
• AstraZeneca plc
• Abbott Laboratories
• Novartis AG
• Thermo Fisher Scientific Inc.
• Fresenius Kabi AG
• GlaxoSmithKline plc
• Danaher Corporation
• Eli Lily and Company
• Siemens Healthineers
• Teva Pharmaceutical Industries Ltd.
• Mylan NV
• Grifols SA

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

• 파종성 혈관 내 응고(DIC) 시장(2029년) : 새로운 기회를 제공하는 국가
• 파종성 혈관 내 응고(DIC) 시장(2029년) : 새로운 기회를 제공하는 부문
• 파종성 혈관 내 응고(DIC) 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

AJY

영문 목차

영문목차

Disseminated intravascular coagulation (DIC) is a severe, life-threatening condition marked by excessive blood clotting, which eventually leads to significant bleeding due to the depletion of clotting factors and platelets. It is triggered by underlying conditions such as sepsis, trauma, malignancies, and obstetric complications.

The primary treatments for disseminated intravascular coagulation (DIC) include medications, transfusions, surgery, and other therapeutic approaches. Medications consist of anticoagulants, blood products, and supportive drugs aimed at managing clotting and bleeding complications related to DIC. Diagnostic methods include a complete blood count with blood smear examination, partial thromboplastin time (PTT), fibrinogen blood test, D-dimer test, and other diagnostic procedures. These tests are administered through various routes, such as oral, parenteral, and alternative methods, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies. Treatment options are utilized across hospitals, specialty clinics, homecare settings, and other healthcare facilities.

The disseminated intravascular coagulation (DIC) market research report is one of a series of new reports from The Business Research Company that provides disseminated intravascular coagulation (DIC) market statistics, including the disseminated intravascular coagulation (DIC) industry's global market size, regional shares, competitors with a disseminated intravascular coagulation (DIC) market share, detailed disseminated intravascular coagulation (DIC) market segments, market trends and opportunities, and any further data you may need to thrive in the disseminated intravascular coagulation (DIC) industry. This disseminated intravascular coagulation (DIC) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The disseminated intravascular coagulation (DIC) market size has grown strongly in recent years. It will grow from $0.46 billion in 2024 to $0.49 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth during the historic period can be attributed to the increasing prevalence of sepsis, a rise in trauma cases, a growing incidence of cancer, higher healthcare expenditures, improved awareness among healthcare professionals, and the increased adoption of targeted therapies.

The disseminated intravascular coagulation (DIC) market size is expected to see strong growth in the next few years. It will grow to $0.59 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth during the forecast period can be attributed to the rising adoption of targeted therapies, increased focus on early disease detection, growing investments in healthcare infrastructure, expansion of clinical research on coagulopathy treatments, and greater awareness of rare hematological conditions. Key trends include advancements in diagnostic assays, adoption of novel anticoagulant therapies, the rise of personalized medicine approaches, integration of AI in diagnostics, improved patient monitoring technologies, and the development of targeted treatments.

The rising incidence of cancer is expected to drive the growth of the disseminated intravascular coagulation (DIC) market. Cancer is a disease characterized by the uncontrolled proliferation and spread of abnormal cells, which can invade and damage normal tissues. The increasing number of cancer cases is attributed to factors such as an aging population, lifestyle changes, environmental exposure, infections, and genetic predisposition. Cancer can lead to disseminated intravascular coagulation (DIC) by excessively activating the coagulation cascade through tumor-produced procoagulant substances, resulting in widespread clotting and bleeding. For example, in May 2024, the National Cancer Institute, a US-based government agency, reported that in 2022, approximately 20 million new cancer cases and 9.7 million cancer-related deaths were recorded globally. Projections indicate that these figures could rise to 29.9 million new cases and 15.3 million deaths annually by 2040. As a result, the increasing prevalence of cancer is fueling the growth of the disseminated intravascular coagulation (DIC) market.

Leading companies in the disseminated intravascular coagulation (DIC) market are advancing coagulation diagnostic technologies, such as next-generation blood clotting tests, to improve diagnostic accuracy, speed, and convenience. These innovations enable timely intervention and enhance patient outcomes. Next-generation blood clotting tests are advanced diagnostic tools designed to assess blood coagulation more precisely, efficiently, and comprehensively than traditional methods. For instance, in June 2022, LumiraDx Limited, a UK-based healthcare company, expanded its cardiovascular testing portfolio by obtaining CE Mark approvals for its NT-proBNP and updated D-Dimer tests. These enhancements strengthen the LumiraDx Platform's ability to assist clinicians in diagnosing heart failure and ruling out venous thromboembolism at the point of care. Such advancements aim to improve the early detection and management of cardiovascular and thrombotic conditions, including disseminated intravascular coagulation (DIC).

In March 2024, MediLink Therapeutics (Suzhou) Co. Ltd., a China-based biotech company, entered into a collaboration with Amgen Inc. to evaluate YL201 for the treatment of thrombotic disorders, including disseminated intravascular coagulation (DIC). This partnership seeks to advance blood clotting therapies, improving treatment effectiveness and patient outcomes. Amgen Inc. is a US-based biopharmaceutical company specializing in the discovery, development, and manufacturing of innovative therapeutics.

Major players in the disseminated intravascular coagulation (DIC) market are Nihon Kohden Corporation, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Danaher Corporation, Eli Lily and Company, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., Mylan N.V., Grifols S.A., Eisai Co. Ltd., Beckman Coulter Inc., Sysmex Corporation, and Bio-Rad Laboratories Inc.

North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2024. The regions covered in disseminated intravascular coagulation (DIC) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the disseminated intravascular coagulation (DIC) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The disseminated intravascular coagulation (DIC) market consists of revenues earned by entities by providing services such as pharmaceutical treatments, anticoagulant therapies, diagnostic services, and critical care interventions. The market value includes the value of related goods sold by the service provider or included within the service offering. The disseminated intravascular coagulation (DIC) market also includes sales of diagnostic tools, anticoagulant medications, and blood products such as platelets, fresh frozen plasma, or cryoprecipitate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Disseminated Intravascular Coagulation (DIC) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on disseminated intravascular coagulation (dic) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for disseminated intravascular coagulation (dic) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The disseminated intravascular coagulation (dic) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Medicines; Transfusions; Surgery; Other Treatments
• 2) By Diagnosis: Complete Blood Count With Blood Smear Exam; Partial Thromboplastin Time (PTT); Fibrinogen Blood Test; D-dimer; Other Diagnoses
• 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
• Subsegments:
• 1) By Medicines: Anticoagulants; Antiplatelet Drugs; Fibrinolytics; Procoagulants; Antithrombin Therapy
• 2) By Transfusions: Platelet Transfusion; Fresh Frozen Plasma (FFP); Cryoprecipitate Transfusion; Red Blood Cell Transfusion
• 3) By Surgery: Surgical Removal Of Thrombus; Organ Surgery
• 4) By Other Treatments: Plasma Exchange; Supportive Care; Steroid Therapy
• Companies Mentioned: Nihon Kohden Corporation; Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Disseminated Intravascular Coagulation (DIC) Market Characteristics

3. Disseminated Intravascular Coagulation (DIC) Market Trends And Strategies

4. Disseminated Intravascular Coagulation (DIC) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Disseminated Intravascular Coagulation (DIC) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Disseminated Intravascular Coagulation (DIC) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Disseminated Intravascular Coagulation (DIC) Market Growth Rate Analysis
• 5.4. Global Disseminated Intravascular Coagulation (DIC) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Disseminated Intravascular Coagulation (DIC) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Disseminated Intravascular Coagulation (DIC) Total Addressable Market (TAM)

6. Disseminated Intravascular Coagulation (DIC) Market Segmentation

• 6.1. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medicines
• Transfusions
• Surgery
• Other Treatments
• 6.2. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Complete Blood Count with Blood Smear Exam
• Partial Thromboplastin Time (PTT)
• Fibrinogen Blood Test
• D-dimer
• Other Diagnoses
• 6.3. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administration
• 6.4. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.5. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Homecare
• Other End-Users
• 6.6. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Medicines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anticoagulants
• Antiplatelet Drugs
• Fibrinolytics
• Procoagulants
• Antithrombin Therapy
• 6.7. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Transfusions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Platelet Transfusion
• Fresh Frozen Plasma (FFP)
• Cryoprecipitate Transfusion
• Red Blood Cell Transfusion
• 6.8. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Removal Of Thrombus
• Organ Surgery
• 6.9. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasma Exchange
• Supportive Care
• Steroid Therapy

7. Disseminated Intravascular Coagulation (DIC) Market Regional And Country Analysis

• 7.1. Global Disseminated Intravascular Coagulation (DIC) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Disseminated Intravascular Coagulation (DIC) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market

• 8.1. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Disseminated Intravascular Coagulation (DIC) Market

• 9.1. China Disseminated Intravascular Coagulation (DIC) Market Overview
• 9.2. China Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Disseminated Intravascular Coagulation (DIC) Market

• 10.1. India Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Disseminated Intravascular Coagulation (DIC) Market

• 11.1. Japan Disseminated Intravascular Coagulation (DIC) Market Overview
• 11.2. Japan Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Disseminated Intravascular Coagulation (DIC) Market

• 12.1. Australia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Disseminated Intravascular Coagulation (DIC) Market

• 13.1. Indonesia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Disseminated Intravascular Coagulation (DIC) Market

• 14.1. South Korea Disseminated Intravascular Coagulation (DIC) Market Overview
• 14.2. South Korea Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Disseminated Intravascular Coagulation (DIC) Market

• 15.1. Western Europe Disseminated Intravascular Coagulation (DIC) Market Overview
• 15.2. Western Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Disseminated Intravascular Coagulation (DIC) Market

• 16.1. UK Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Disseminated Intravascular Coagulation (DIC) Market

• 17.1. Germany Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Disseminated Intravascular Coagulation (DIC) Market

• 18.1. France Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Disseminated Intravascular Coagulation (DIC) Market

• 19.1. Italy Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Disseminated Intravascular Coagulation (DIC) Market

• 20.1. Spain Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market

• 21.1. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market Overview
• 21.2. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Disseminated Intravascular Coagulation (DIC) Market

• 22.1. Russia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Disseminated Intravascular Coagulation (DIC) Market

• 23.1. North America Disseminated Intravascular Coagulation (DIC) Market Overview
• 23.2. North America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Disseminated Intravascular Coagulation (DIC) Market

• 24.1. USA Disseminated Intravascular Coagulation (DIC) Market Overview
• 24.2. USA Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Disseminated Intravascular Coagulation (DIC) Market

• 25.1. Canada Disseminated Intravascular Coagulation (DIC) Market Overview
• 25.2. Canada Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Disseminated Intravascular Coagulation (DIC) Market

• 26.1. South America Disseminated Intravascular Coagulation (DIC) Market Overview
• 26.2. South America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Disseminated Intravascular Coagulation (DIC) Market

• 27.1. Brazil Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Disseminated Intravascular Coagulation (DIC) Market

• 28.1. Middle East Disseminated Intravascular Coagulation (DIC) Market Overview
• 28.2. Middle East Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Disseminated Intravascular Coagulation (DIC) Market

• 29.1. Africa Disseminated Intravascular Coagulation (DIC) Market Overview
• 29.2. Africa Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Disseminated Intravascular Coagulation (DIC) Market Competitive Landscape And Company Profiles

• 30.1. Disseminated Intravascular Coagulation (DIC) Market Competitive Landscape
• 30.2. Disseminated Intravascular Coagulation (DIC) Market Company Profiles
  • 30.2.1. Nihon Kohden Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Disseminated Intravascular Coagulation (DIC) Market Other Major And Innovative Companies

• 31.1. Merck & Co.Inc.
• 31.2. Bayer AG
• 31.3. Sanofi S.A.
• 31.4. AstraZeneca plc
• 31.5. Abbott Laboratories
• 31.6. Novartis AG
• 31.7. Thermo Fisher Scientific Inc.
• 31.8. Fresenius Kabi AG
• 31.9. GlaxoSmithKline plc
• 31.10. Danaher Corporation
• 31.11. Eli Lily and Company
• 31.12. Siemens Healthineers
• 31.13. Teva Pharmaceutical Industries Ltd.
• 31.14. Mylan N.V.
• 31.15. Grifols S.A.

32. Global Disseminated Intravascular Coagulation (DIC) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Disseminated Intravascular Coagulation (DIC) Market

34. Recent Developments In The Disseminated Intravascular Coagulation (DIC) Market

35. Disseminated Intravascular Coagulation (DIC) Market High Potential Countries, Segments and Strategies

• 35.1 Disseminated Intravascular Coagulation (DIC) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Disseminated Intravascular Coagulation (DIC) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Disseminated Intravascular Coagulation (DIC) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료